← Back to Influence Map
Entity DossierOrganization
SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)
DC · US
A bio company focused on developing and applying advanced technologies in the life science
pharmaceuticals
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$300,000
Connections
3
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
BUDBudget/Appropriations
$360KMMMMedicare/Medicaid
$360KHCRHealth Issues
$360KTAXTaxation/Internal Revenue Code
$240KCPTCopyright/Patent/Trademark
$120KLobbying Firms Retained
TARPLIN, DOWNS & YOUNG, LLC$360K
Bills Referenced in Lobbying Filings
insulin
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Lobbied for | Insulin Price Caps - State-Level Legislation | LDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Employed by | TARPLIN, DOWNS & YOUNG, LLC | Hired TARPLIN, DOWNS & YOUNG, LLC to lobby on Insulin Price Caps | Source |
| Subsidiary of | SANOFI US SERVICES INC | Genzyme is a subsidiary of Sanofi, acquired in 2011 | Source |